These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17710682)

  • 1. Strong activation of PAR-2 receptors: a common trigger for the development of gastrointestinal adenocarcinomas?
    Olbe L
    Scand J Gastroenterol; 2007 Sep; 42(9):1133-7. PubMed ID: 17710682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastroesophageal reflux disease and Helicobacter pylori infection].
    Naumovski-Mihalić S; Sabarić B; Filipec T; Tićak M; Prskalo M; Skurla B; Papa B; Dominis M; Katicić M
    Lijec Vjesn; 2002 Sep; 124 Suppl 1():52-6. PubMed ID: 12592818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori and acid peptic disorders of the esophagus: is it conceivable?
    Vicari J; Falk GW; Richter JE
    Am J Gastroenterol; 1997 Jul; 92(7):1097-102. PubMed ID: 9219777
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan.
    Koike T; Ohara S; Inomata Y; Abe Y; Iijima K; Shimosegawa T
    Inflammopharmacology; 2007 Apr; 15(2):61-4. PubMed ID: 17450443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections of the esophagus and the stomach.
    Quiding-Järbrink M; Bove M; Dahlén G
    Periodontol 2000; 2009 Feb; 49():166-78. PubMed ID: 19152533
    [No Abstract]   [Full Text] [Related]  

  • 6. [Esophageal adenocarcinoma after Helicobacter pylori eradication].
    Miyazaki S; Aoki T; Okazaki Y; Ochiai T; Kamitsu T
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():527-30. PubMed ID: 16363594
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology of esophageal adenocarcinoma.
    Pera M; Manterola C; Vidal O; Grande L
    J Surg Oncol; 2005 Dec; 92(3):151-9. PubMed ID: 16299786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for esophageal cancer development.
    Falk GW
    Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between Helicobacter pylori and gastroesophageal reflux disease.
    Bowrey DJ; Williams GT; Clark GW
    Dis Esophagus; 1998 Oct; 11(4):203-9. PubMed ID: 10071799
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in trends and fashions in the upper gastrointestinal tract: focus on the esophagus].
    Malfertheiner P
    Z Gastroenterol; 2003 Dec; 41(12):1135-6. PubMed ID: 14661121
    [No Abstract]   [Full Text] [Related]  

  • 11. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Helicobacter pylori and gastric adenocarcinoma].
    Arfaoui D; Elloumi H; Ben Abdelaziz A
    Tunis Med; 2009 Apr; 87(4):231-6. PubMed ID: 19835277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett's oesophagus.
    Kountouras J; Chatzopoulos D; Zavos C
    Med Hypotheses; 2007; 68(5):1174-5. PubMed ID: 17196756
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of protease-activated-receptor 2 (PAR-2) in human esophageal mucosa.
    Inci K; Edebo A; Olbe L; Casselbrant A
    Scand J Gastroenterol; 2009; 44(6):664-71. PubMed ID: 19263271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why is esophageal adenocarcinoma increasing in incidence?
    Falk GW; Richter JE
    Abdom Imaging; 1998; 23(5):539-42. PubMed ID: 9841072
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between Helicobacter pylori gastritis, gastric cancer and gastric acid secretion.
    Axon AT
    Adv Med Sci; 2007; 52():55-60. PubMed ID: 18217390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection: mainly foe but also friend?
    Nyrén O; Blot WJ
    J Natl Cancer Inst; 2006 Oct; 98(20):1432-4. PubMed ID: 17047185
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenesis and classification of cancer around the gastroesophageal junction--not so different in Japan.
    Dent J
    Am J Gastroenterol; 2006 May; 101(5):934-6. PubMed ID: 16696780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of telomerase by site-specific ribonucleases in gastric and esophageal adenocarcinoma.
    Usselmann B; Portsmouth D; Barclay J; Morris AG; Nwokolo CU
    Dig Dis Sci; 2001 Dec; 46(12):2666-72. PubMed ID: 11768258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of bile and acid reflux into the esophagus.
    Netzer P; Inauen W
    Am J Gastroenterol; 2002 Jan; 97(1):207. PubMed ID: 11808955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.